ag011

Cell therapyexperimental

Clinical trial activity

1 trials · 16 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0

Earliest trial started Jul 1, 2008 (NCT00729872)

Timeline

2000s

  1. Jan 1, 2008

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

  • microbiotaTissue restoration

    microbiota tissue restoration

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • ag011

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT00729872Phase 1/Phase 2 (Phase 2)Jul 1, 2008ActoGeniX, AZ Groeninge, Imelda Hospital, Bonheiden, Karolinska Institute, Katholieke Universiteit Leuven, Leiden University, Lund University, Orebro University, Queen's University, Belfast, Universitair Ziekenhuis Gent, University of Antwerp, University of British Columbia, University of London, University of Ottawa, University of Toronto, University of Western Ontario
Showing 1 of 1 trials
Page 1 / 1

Organizations

Research & Development (16)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
ActoGeniXFor profit1112008
AZ GroeningeAcademic/Hospital1012008
Imelda Hospital, BonheidenAcademic/Hospital1012008
Karolinska InstituteAcademic/Hospital1012008
Katholieke Universiteit LeuvenAcademic/Hospital1012008
Leiden UniversityAcademic/Hospital1012008
Lund UniversityAcademic/Hospital1012008
Orebro UniversityAcademic/Hospital1012008
Queen's University, BelfastAcademic/Hospital1012008
Universitair Ziekenhuis GentAcademic/Hospital1012008
University of AntwerpAcademic/Hospital1012008
University of British ColumbiaAcademic/Hospital1012008
University of LondonAcademic/Hospital1012008
University of OttawaAcademic/Hospital1012008
University of TorontoAcademic/Hospital1012008
University of Western OntarioAcademic/Hospital1012008
16 organizations
Page 1 / 1